ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,201 | 77.82599 | 0 | female | 0 | 28 | 1,503 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | $25-$50k | 0 | 59,663 | 27,647.4062 | null | 21.25 | white | 23.097656 | 30 | 0.7229 | 0.637939 | 7 | 0 | 0 | no | 0.7 | 0.4 | dnr before sadm | -4 | 60 | 5.799805 | 49 | 24 | 36.19531 | 300 | 2.799805 | null | 1.899902 | 137 | 7.449219 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
2,202 | 82.35498 | 1 | female | 0 | 7 | 252 | Coma | Coma | 2 | 18 | $25-$50k | 100 | 5,849 | 3,759.3828 | null | 8 | white | 15.699219 | 17 | 0.268982 | 0.200989 | 1 | 0 | 1 | no | 0.5 | 0.25 | dnr after sadm | 1 | 113 | 6.299805 | 60 | 20 | 36.39844 | null | null | null | 1 | 139 | null | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
2,203 | 87.61096 | 1 | male | 0 | 87 | 129 | CHF | COPD/CHF/Cirrhosis | 5 | 8 | under $11k | 0 | 77,925 | 50,186.2812 | null | 8.75 | white | 20.5 | 36 | 0.774902 | 0.640991 | 1 | 1 | 0 | no | 0.4 | 0.2 | dnr after sadm | 1 | 107 | 9.398438 | 60 | 20 | 36.59375 | 218.5 | null | null | 2.099609 | 145 | 7.479492 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
2,204 | 50.81497 | 0 | female | 0 | 6 | 1,501 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 6,782 | 4,035.1836 | null | 13 | black | 23.597656 | 39 | 0.86499 | 0.775879 | 1 | 1 | 0 | no | 0.98 | 0.95 | no dnr | 6 | 73 | 4.5 | 70 | 20 | 36.69531 | null | 2.799805 | 0.299988 | 5.699219 | 139 | 7.389648 | null | null | null | 0 | 0 | null | 0 |
2,205 | 34.54099 | 0 | female | 0 | 21 | 1,500 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 19 | null | 0 | 55,377 | 22,339.2344 | null | 32 | white | 18.699219 | 32 | 0.925903 | 0.898926 | 1 | 0 | 0 | no | 0.98 | 0.98 | no dnr | 21 | 63 | 7.799805 | 142 | 14 | 38.39844 | 202 | 3.099609 | 0.799927 | 1.299805 | 139 | 7.429688 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
2,206 | 83.08795 | 1 | female | 1 | 34 | 34 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | under $11k | 89 | 43,926 | 24,020.4688 | null | 17.5 | black | 42.5 | 67 | 0.007999 | 0.001 | 1 | 0 | 0 | no | 0.6 | 0.4 | dnr after sadm | 1 | 43 | 26.097656 | 120 | 24 | 34.69531 | 504 | 2.299805 | 0.299988 | 6.299805 | 149 | 7.359375 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
2,207 | 67.53198 | 1 | female | 0 | 15 | 283 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 25,469 | 9,964.6797 | null | 22 | white | 25 | 30 | 0.782959 | 0.712891 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 15 | 52 | 5.299805 | 64 | 8 | 37.79688 | 195 | 3 | null | 0.699951 | 134 | 7.179688 | null | null | null | null | null | null | 2.063965 |
2,208 | 64.13696 | 1 | male | 0 | 19 | 1,106 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $25-$50k | 0 | 50,784 | 39,553.5312 | null | 30 | white | 21.5 | 43 | 0.759888 | 0.68396 | 6 | 1 | 0 | yes | 0.95 | 0.9 | no dnr | 19 | 70 | 13 | 125 | 33 | 38.19531 | 296 | null | null | 1.099854 | 135 | 7.429688 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
2,209 | 89.83698 | 1 | female | 0 | 8 | 63 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | $11-$25k | 0 | 11,439 | 5,436.3047 | null | 8.5 | white | 31.199219 | 40 | 0.510986 | 0.393982 | 2 | 0 | 0 | no | null | null | no dnr | 8 | 123 | 5.599609 | 80 | 30 | 36.19531 | 118.32812 | 3 | 0.399963 | 3.899902 | 144 | 7.449219 | null | null | null | 1 | 1 | null | 1 |
2,210 | 57.20697 | 0 | male | 0 | 12 | 1,497 | Colon Cancer | Cancer | 2 | 14 | $25-$50k | 0 | 18,587 | 10,156.1484 | null | 11.5 | white | 2.699707 | 21 | 0.94397 | 0.865967 | 1 | 0 | 0 | metastatic | 0.99 | 0.5 | no dnr | 12 | 77 | 5.699219 | 70 | 15 | 36.09375 | null | 4.699219 | 0.5 | 1.099854 | 136 | null | null | null | null | 0 | 0 | null | 0 |
2,211 | 84.50897 | 1 | male | 1 | 13 | 13 | Coma | Coma | 2 | 6 | under $11k | 89 | 29,340 | 11,978.5312 | null | 32 | white | 20.296875 | 46 | 0.176971 | 0.120987 | 1 | 0 | 0 | no | 0.25 | 0.15 | dnr after sadm | 9 | 69 | 7.399414 | 158 | 30 | 38.19531 | 420 | 2.399902 | 0.5 | 1.299805 | 149 | 7.439453 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
2,212 | 80.91998 | 1 | female | 0 | 11 | 13 | COPD | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 16,313 | 7,441.9102 | null | 18.5 | white | 22.296875 | 23 | 0.736938 | 0.586914 | 1 | 0 | 1 | no | 0.9 | 0.5 | dnr after sadm | 8 | 67 | 8.699219 | 128 | 8 | 37.79688 | 206.65625 | null | null | 0.5 | 135 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 4.399414 |
2,213 | 70.23999 | 0 | female | 0 | 15 | 1,490 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | $11-$25k | 0 | 19,161 | 13,954.1172 | null | 16.333328 | white | 18.898438 | 31 | 0.85498 | 0.804932 | 1 | 1 | 0 | no | 0.7 | 0.3 | no dnr | 15 | 64 | 8.199219 | 64 | 20 | 38.09375 | 130.59375 | null | null | 1.199951 | 135 | 7.469727 | null | null | null | 2 | 1 | no(M2 and SIP pres) | 1 |
2,214 | 44.04898 | 1 | female | 0 | 6 | 39 | Colon Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 7,996 | 4,786.5938 | null | 20 | black | 36.296875 | 24 | 0.462952 | 0.148987 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | no dnr | 6 | 103 | 17.699219 | 120 | 24 | 39.39844 | null | 2.299805 | 1.199951 | 0.699951 | 134 | null | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
2,215 | 84.70898 | 1 | male | 0 | 10 | 498 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | under $11k | 9 | 22,238 | 12,097.125 | null | 8.5 | white | 24.097656 | 35 | 0.620972 | 0.515991 | 10 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 10 | 117 | 10.699219 | 70 | 26 | 36.19531 | 471.625 | 3.899902 | 0.5 | 2.799805 | 145 | 7.419922 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
2,216 | 22.61699 | 0 | female | 0 | 19 | 1,487 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | >$50k | 0 | 77,442 | 32,460.3125 | null | 19.666656 | white | 22.597656 | 18 | 0.886963 | 0.846924 | 24 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 19 | 63 | 5.799805 | 126 | 8 | 38.19531 | 503.3125 | null | null | 0.5 | 135 | 7.419922 | null | null | null | null | 0 | SIP>=30 | 0 |
2,217 | 61.07898 | 1 | male | 1 | 34 | 34 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 0 | 106,796 | 36,357.6562 | null | 33.25 | white | 27.796875 | 24 | 0.762939 | 0.687988 | 1 | 0 | 0 | no | 0.65 | 0.5 | no dnr | 34 | 47 | 6.399414 | 66 | 6 | 36.09375 | 253.3125 | 2.699707 | 0.399963 | 0.399963 | 136 | 7.349609 | null | null | null | null | null | <2 mo. follow-up | 2.493652 |
2,218 | 70.36597 | 1 | female | 0 | 6 | 1,339 | Lung Cancer | Cancer | 1 | null | null | 0 | 6,223 | 3,822.707 | null | 19 | null | 14.298828 | 9 | 0.746948 | 0.484985 | 1 | 0 | 0 | metastatic | 0.9 | 0.8 | no dnr | 6 | 83 | 5.099609 | 84 | 20 | 36.69531 | null | null | null | 0.899902 | 144 | null | null | null | null | null | null | null | 2.637207 |
2,219 | 38.448 | 1 | female | 1 | 34 | 34 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 88,669 | 31,513.9062 | null | 32.5 | white | 24 | 40 | 0.879883 | 0.837891 | 1 | 0 | 0 | no | 0.8 | 0.8 | dnr after sadm | 29 | 119 | 4.599609 | 64 | 20 | 37.79688 | 204.75 | 3.199707 | 0.099991 | 3.599609 | 142 | 7.359375 | null | null | null | null | null | <2 mo. follow-up | 1.805908 |
2,220 | 43.23898 | 0 | male | 0 | 11 | 1,482 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | $11-$25k | 0 | 40,025 | 30,081.8594 | null | 34.5 | white | 21.699219 | 30 | 0.870972 | 0.825928 | 4 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 11 | 70 | 16.597656 | 70 | 38 | 39.29688 | 190 | null | 1.399902 | 0.899902 | 134 | 7.339844 | null | null | null | null | null | no(M2 and SIP pres) | 1.980957 |
2,221 | 69.45898 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 9 | 54,062 | 41,957.7812 | null | 56 | white | 33.59375 | 62 | 0.462952 | 0.343994 | 10 | 1 | 0 | no | 0.75 | 0.6 | no dnr | 7 | 45 | 19.296875 | 120 | 46 | 39.09375 | 248 | 2.299805 | null | 1.199951 | 149 | 7.519531 | null | null | null | null | null | <2 mo. follow-up | 2.476563 |
2,222 | 80.37195 | 1 | female | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | $25-$50k | 0 | 28,526 | 9,979.5781 | null | 40 | white | 20.898438 | 30 | 0.766968 | 0.691895 | 4 | 0 | 0 | no | 0 | 0 | no dnr | 7 | 61 | 13.099609 | 133 | 12 | 38.69531 | 215 | 1.799805 | 0.5 | 0.799927 | 142 | 7.389648 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
2,223 | 55.93198 | 1 | female | 0 | 10 | 792 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 14 | null | 0 | 25,230 | 10,519.9688 | null | 28 | black | 25.097656 | 57 | 0.79895 | 0.73291 | 3 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 10 | 61 | 10 | 110 | 6 | 36.59375 | 216 | 2.5 | 0.299988 | 2.799805 | 134 | 7.469727 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,224 | 46.10797 | 0 | male | 0 | 226 | 1,480 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | null | 0 | 421,711 | 264,855 | null | 42.5 | white | 32.898438 | 50 | 0.736938 | 0.654907 | 1 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 226 | 51 | 15.699219 | 140 | 43 | 38.89844 | 202.5 | 2.199707 | 1.599854 | 0.899902 | 153 | 7.439453 | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.174805 |
2,225 | 50.64499 | 1 | male | 0 | 7 | 706 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 17 | under $11k | 9 | 8,764 | 5,128.2109 | null | 10 | white | 16.296875 | 22 | 0.861938 | 0.770996 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 7 | 97 | 5.299805 | 80 | 20 | 37 | null | 2.899902 | 1.899902 | 1.5 | 134 | null | null | null | null | 6 | 1 | no(M2 and SIP pres) | 1 |
2,226 | 62.48599 | 1 | female | 1 | 9 | 9 | Colon Cancer | Cancer | 1 | null | null | 0 | 7,395 | 4,865.1836 | null | 9 | white | 46.59375 | 47 | 0.113998 | 0.004999 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 70 | 22 | 110 | 22 | 35.59375 | null | 2.199707 | 14 | 0.699951 | 134 | null | null | null | null | 5 | null | <2 mo. follow-up | 3.855299 |
2,227 | 54.32999 | 0 | male | 0 | 9 | 1,477 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $11-$25k | 0 | 46,721 | 35,097.75 | null | 9 | white | 24.597656 | 23 | 0.774902 | 0.701904 | 17 | 0 | 0 | no | 1 | 1 | no dnr | 9 | 75 | 13.398438 | 110 | 30 | 38.29688 | 178 | null | null | 0.699951 | 134 | 7.349609 | null | null | null | 2 | 1 | no(M2 and SIP pres) | 1 |
2,228 | 65.65594 | 1 | female | 0 | 14 | 108 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 32,779 | 12,959.2578 | null | 34.666657 | white | 26.699219 | 34 | 0.664917 | 0.567993 | 4 | 0 | 0 | yes | 0.75 | 0.5 | no dnr | 14 | 58 | 5.199219 | 137 | 30 | 38.39844 | 230 | 3.399902 | null | 0.5 | 134 | 7.399414 | null | null | null | null | null | no(M2 and SIP pres) | 2.080078 |
2,229 | 84.16998 | 1 | female | 1 | 6 | 6 | Coma | Coma | 2 | 12 | under $11k | 61 | 9,943 | 3,755.8301 | null | 28 | white | 28.097656 | 30 | 0.11499 | 0.070999 | 1 | 0 | 0 | no | 0.1 | 0.001 | dnr before sadm | 0 | 69 | 13.398438 | 112 | 24 | 38.89844 | 120 | 4 | 1.099854 | 1.699951 | 144 | 7.429688 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
2,230 | 64.47595 | 1 | male | 0 | 6 | 68 | Lung Cancer | Cancer | 2 | 16 | >$50k | 0 | 6,831 | 4,204.0312 | null | 11 | white | 9.898438 | 17 | 0.823975 | 0.619995 | 1 | 0 | 0 | metastatic | 0.75 | 0 | no dnr | 6 | 109 | 7.199219 | 96 | 16 | 35.89844 | null | 3.299805 | 1.399902 | 1.099854 | 136 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,231 | 64.211 | 1 | male | 0 | 33 | 137 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $25-$50k | 0 | 67,530 | 49,720.875 | null | 28.5 | white | 28.097656 | 36 | 0.713989 | 0.626953 | 3 | 0 | 0 | no | 0.5 | 0.25 | no dnr | 33 | 118 | 9.5 | 68 | 12 | 38 | 67.5 | null | 0.299988 | 6.799805 | 136 | 7.419922 | null | null | null | null | 3 | adl>=4 (>=5 if sur) | 3 |
2,232 | 65.59094 | 0 | female | 0 | 19 | 1,475 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | >$50k | 0 | 33,458 | 13,394.7031 | null | 17.666656 | white | 26.898438 | 34 | 0.721924 | 0.636963 | 4 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 19 | 53 | 7.799805 | 80 | 38 | 39.69531 | 126.65625 | 3.299805 | 0.299988 | 0.599976 | 138 | 7.509766 | null | null | null | 0 | 2 | no(M2 and SIP pres) | 2 |
2,233 | 52.62097 | 1 | male | 1 | 17 | 17 | MOSF w/Malig | ARF/MOSF | 1 | 20 | >$50k | 0 | 97,248 | 46,806.2188 | null | 45.666657 | white | 47.398438 | 60 | 0.059998 | 0.019997 | 6 | 0 | 0 | yes | 0.05 | 0.000125 | dnr after sadm | 2 | 46 | 80.59375 | 72 | 28 | 37.89844 | 87.14062 | 2.899902 | 1.799805 | 3.699707 | 125 | 7.349609 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
2,234 | 55.32898 | 1 | female | 0 | 31 | 32 | Lung Cancer | Cancer | 2 | null | null | 0 | 36,321 | 23,353.5781 | null | 13 | white | 13.398438 | 15 | 0.790894 | 0.55896 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | dnr after sadm | 13 | 103 | 8.5 | 70 | 20 | 35.69531 | null | 4.099609 | 0.599976 | 0.599976 | 137 | null | null | null | null | null | null | <2 mo. follow-up | 2.228516 |
2,235 | 68.81 | 1 | female | 1 | 3 | 3 | COPD | COPD/CHF/Cirrhosis | 2 | null | under $11k | 0 | 3,666 | 2,116.4824 | null | 21 | white | 27.296875 | 37 | 0.61499 | 0.427979 | 1 | 0 | 0 | metastatic | 0.02 | 0.000008 | dnr after sadm | 1 | 60 | 12.398438 | 120 | 20 | 35.59375 | 219.03125 | null | null | 0.599976 | 131 | 7.30957 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
2,236 | 61.62097 | 1 | female | 0 | 6 | 314 | Lung Cancer | Cancer | 1 | 12 | >$50k | 0 | 6,666 | 3,844.1074 | null | 10 | white | 6.399414 | 11 | 0.86792 | 0.704956 | 1 | 0 | 0 | metastatic | 0.8 | 0.6 | no dnr | 6 | 97 | 4.399414 | 100 | 20 | 36.09375 | null | 4.599609 | null | 0.699951 | 142 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,237 | 76.56897 | 0 | male | 0 | 19 | 1,460 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 29,690 | 15,245.2891 | null | 16 | white | 22.597656 | 35 | 0.753906 | 0.675903 | 4 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 19 | 53 | 5.399414 | 63 | 30 | 38.59375 | 220 | null | 0.5 | 0.799927 | 136 | 7.419922 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,238 | 73.85596 | 1 | male | 1 | 10 | 10 | Coma | Coma | 1 | 12 | $25-$50k | 44 | 17,288 | 6,808.6406 | null | 25.5 | white | 19.097656 | 14 | 0.544922 | 0.475952 | 1 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 5 | 71 | 11 | 114 | 8 | 38.5 | 232.5 | 3.699707 | 0.699951 | 0.799927 | 135 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
2,239 | 84.27698 | 1 | male | 0 | 22 | 495 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 16 | null | 0 | 53,017 | 33,306.75 | null | 25.333328 | white | 26.699219 | 42 | 0.643921 | 0.542969 | 3 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 22 | 63 | 29.796875 | 60 | 6 | 35.59375 | 166 | null | null | 1.799805 | 138 | 7.439453 | null | null | null | 5 | 0 | no(M2 and SIP pres) | 0 |
2,240 | 51.92297 | 0 | female | 0 | 13 | 1,458 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 30,647 | 14,629.6094 | null | 14.5 | white | 15.898438 | 16 | 0.916992 | 0.886963 | 1 | 0 | 0 | no | 0.99 | 0.98 | no dnr | 13 | 100 | 6.899414 | 65 | 16 | 38.19531 | 198 | 2.899902 | 0.799927 | 0.699951 | 139 | 7.279297 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,241 | 72.90594 | 1 | male | 0 | 12 | 1,068 | CHF | COPD/CHF/Cirrhosis | 1 | 13 | under $11k | 0 | 19,699 | 12,867.1562 | null | 21.5 | white | 22.699219 | 40 | 0.800903 | 0.679932 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 12 | 129 | 12 | 100 | 12 | 36.19531 | 270 | null | null | 2.199707 | 139 | 7.429688 | null | null | null | 0 | 2 | no(M2 and SIP pres) | 2 |
2,242 | 59.09097 | 1 | male | 0 | 11 | 18 | Lung Cancer | Cancer | 1 | 12 | under $11k | 0 | 13,003 | 7,888.3828 | null | 12 | white | 26.5 | 14 | 0.494995 | 0.174988 | 1 | 0 | 0 | metastatic | 0 | 0 | dnr after sadm | 1 | 87 | 10 | 100 | 25 | 36.69531 | null | 2.899902 | 0.5 | 0.699951 | 134 | null | null | null | null | 0 | 6 | <2 mo. follow-up | 6 |
2,243 | 83.35095 | 1 | female | 0 | 11 | 65 | CHF | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 13,550 | 8,018.4453 | null | 17 | white | 19.296875 | 37 | 0.809937 | 0.692993 | 1 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 11 | 110 | 7.699219 | 70 | 25 | 36.59375 | null | null | 0.899902 | 2.099609 | 140 | null | null | null | null | 3 | 5 | null | 5 |
2,244 | 63.59198 | 1 | male | 0 | 8 | 91 | Colon Cancer | Cancer | 1 | 17 | >$50k | 0 | 12,101 | 7,983.332 | null | 3.5 | black | 33.695313 | 23 | 0.460999 | 0.146973 | 1 | 0 | 0 | metastatic | 0.3 | 0.1 | no dnr | 8 | 117 | 18.5 | 80 | 20 | 35.19531 | null | 2.799805 | 4.399414 | 0.699951 | 131 | null | null | null | null | 5 | 5 | adl>=4 (>=5 if sur) | 5 |
2,245 | 21.28099 | 0 | female | 0 | 22 | 1,459 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 32,860 | 20,276.2344 | null | 20 | black | 25.398438 | 27 | 0.893921 | 0.856934 | 2 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 22 | 68 | 17.097656 | 136 | 30 | 40.29688 | 359.25 | null | null | 0.699951 | 141 | 7.399414 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
2,246 | 89.10095 | 1 | male | 1 | 90 | 90 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 7 | under $11k | 0 | 116,854 | 92,010.6875 | null | 32 | white | 31.5 | 44 | 0.532959 | 0.417969 | 1 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 90 | 53 | 21.597656 | 110 | 24 | 38.09375 | 156 | 3.299805 | 0.699951 | 1.299805 | 128 | 7.369141 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
2,247 | 74.65796 | 0 | female | 0 | 23 | 1,454 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 8 | under $11k | 0 | 26,459 | 14,287.1172 | null | 13.666664 | white | 37 | 63 | 0.475952 | 0.356995 | 1 | 0 | 0 | no | 0.85 | 0.8 | no dnr | 23 | 53 | 31.398438 | 120 | 36 | 36.09375 | 392.5625 | 2.899902 | 0.399963 | 2.299805 | 128 | 7.399414 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
2,248 | 70.935 | 1 | male | 0 | 16 | 81 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 28,416 | 15,437.4375 | null | 14.666664 | white | 18.199219 | 19 | 0.860962 | 0.812988 | 1 | 0 | 0 | no | 0.5 | 0.3 | dnr after sadm | 1 | 73 | 18.199219 | 98 | 22 | 36.29688 | 294.25 | 2.199707 | 0.599976 | 0.899902 | 139 | 7.399414 | null | null | null | 4 | 4 | no(M2 and SIP pres) | 4 |
2,249 | 40.099 | 1 | male | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 10 | under $11k | 0 | 27,665 | 9,428.0156 | null | 39 | black | 40.796875 | 68 | 0.595947 | 0.487976 | 1 | 0 | 0 | no | 0.7 | 0.7 | dnr after sadm | 5 | 55 | 23.296875 | 106 | 42 | 38.09375 | 160 | 2 | 25.699219 | 1.899902 | 143 | 7.379883 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
2,250 | 75.09698 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | $11-$25k | 0 | 41,196 | 27,988.9375 | null | 49 | white | 30.597656 | 60 | 0.562988 | 0.450989 | 8 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 6 | 52 | 26.796875 | 113 | 8 | 40.09375 | 317 | null | null | 2 | 145 | 7.549805 | null | null | null | null | null | <2 mo. follow-up | 2.090332 |
2,251 | 65.62396 | 1 | male | 0 | 22 | 377 | Lung Cancer | Cancer | 1 | 8 | null | 0 | 37,795 | 20,885.0156 | null | 19.666656 | white | 26.296875 | 54 | 0.475952 | 0.158997 | 1 | 0 | 0 | metastatic | 0.85 | 0.75 | dnr after sadm | 20 | 73 | 0.899902 | 140 | 24 | 38.29688 | null | 2.899902 | null | 1.399902 | 134 | 7.489258 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
2,252 | 39.61899 | 1 | female | 0 | 7 | 111 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 0 | 12,213 | 5,289.6758 | null | 21 | white | 30.597656 | 32 | 0.799927 | 0.733887 | 1 | 1 | 0 | no | null | null | no dnr | 7 | 43 | 4.599609 | 74 | 20 | 38.39844 | 466.625 | 2.099609 | 0.399963 | 0.399963 | 132 | 7.469727 | null | null | null | null | null | null | 3.415527 |
2,253 | 96.70599 | 1 | male | 0 | 7 | 93 | COPD | COPD/CHF/Cirrhosis | 3 | null | under $11k | 26 | 7,407 | 4,494.0625 | null | 11 | white | 16.898438 | 26 | 0.611938 | 0.42395 | 1 | 0 | 1 | no | 0.75 | 0.75 | dnr before sadm | -1 | 103 | 3.299805 | 70 | 25 | 37 | 417.125 | 3.099609 | 0.299988 | 1.199951 | 138 | 7.379883 | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
2,254 | 88.159 | 1 | male | 0 | 40 | 43 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 8 | $11-$25k | 0 | 59,176 | 42,419.75 | null | 23.5 | white | 12.199219 | 21 | 0.879883 | 0.836914 | 1 | 0 | 1 | no | 0.1 | 0.001 | dnr after sadm | 2 | 60 | 7.899414 | 69 | 10 | 38.79688 | 232.5 | 2.5 | 1.099854 | 0.899902 | 140 | 7.399414 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
2,255 | 73.08698 | 1 | male | 0 | 20 | 48 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | $25-$50k | 0 | 19,910 | 12,320.1172 | null | 13 | white | 24.398438 | 36 | 0.723999 | 0.569946 | 1 | 1 | 0 | yes | 0.4 | 0.2 | dnr after sadm | 1 | 83 | 11.898438 | 80 | 25 | 36.69531 | 305 | 3.099609 | 1.099854 | 2.299805 | 134 | 7.40918 | null | null | null | 4 | 3 | <2 mo. follow-up | 3 |
2,256 | 74.55695 | 0 | male | 0 | 28 | 1,449 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 50,568 | 32,572.0625 | null | 23.75 | white | 25.699219 | 42 | 0.726929 | 0.642944 | 2 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 28 | 52 | 11.5 | 64 | 10 | 38.19531 | 191.40625 | null | 1.099854 | 1.899902 | 138 | 7.40918 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
2,257 | 76.271 | 0 | female | 0 | 33 | 1,449 | MOSF w/Malig | ARF/MOSF | 3 | 16 | null | 0 | 79,339 | 59,362 | null | 34.25 | white | 30.796875 | 53 | 0.417969 | 0.297974 | 9 | 1 | 0 | yes | null | null | dnr after sadm | 2 | 62 | 7.399414 | 113 | 26 | 38.5 | 59 | 2.199707 | null | 1.199951 | 130 | 7.459961 | null | null | null | null | 1 | SIP>=30 | 1 |
2,258 | 85.39398 | 1 | female | 0 | 9 | 194 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | null | 0 | 10,243 | 7,546.2773 | null | 16 | white | 18.796875 | 19 | 0.812988 | 0.75 | 1 | 0 | 0 | no | 0.5 | 0.2 | no dnr | 9 | 100 | 10.599609 | 65 | 24 | 38.69531 | 288 | null | 0.899902 | 0.599976 | 132 | 7.469727 | null | null | null | null | 5 | adl>=4 (>=5 if sur) | 5 |
2,259 | 65.77698 | 1 | male | 0 | 10 | 31 | Lung Cancer | Cancer | 1 | null | null | 0 | 13,376 | 8,313.875 | null | 14 | white | 38.898438 | 29 | 0.126984 | 0.006 | 1 | 0 | 0 | metastatic | 0.9 | 0.85 | no dnr | 10 | 73 | 9.898438 | 110 | 15 | 35.59375 | null | 1.899902 | null | 0.899902 | 137 | null | null | null | null | null | null | <2 mo. follow-up | 3.240234 |
2,260 | 95.00098 | 1 | male | 0 | 33 | 855 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 51,385 | 38,111.875 | null | 15 | white | 20.898438 | 37 | 0.74292 | 0.661987 | 1 | 0 | 0 | no | 0.7 | 0.5 | dnr after sadm | 25 | 109 | 5 | 68 | 24 | 36.29688 | 230 | 3.099609 | 0.399963 | 10.298828 | 144 | 7.15918 | null | null | null | 5 | 2 | no(M2 and SIP pres) | 2 |
2,261 | 95.65796 | 1 | male | 0 | 6 | 287 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 7 | under $11k | 0 | 12,752 | 6,904.0234 | null | 18 | white | 16.898438 | 24 | 0.728882 | 0.644897 | 3 | 0 | 0 | yes | 0.8 | 0.6 | no dnr | 6 | 97 | 7.399414 | 100 | 25 | 36.69531 | 386.625 | 2.699707 | null | 1 | 141 | 7.469727 | null | null | null | 6 | 2 | adl>=4 (>=5 if sur) | 2 |
2,262 | 81.93597 | 1 | male | 0 | 17 | 188 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | under $11k | 0 | 23,223 | 16,159.3828 | null | 21 | white | 18.898438 | 34 | 0.821899 | 0.761963 | 1 | 1 | 0 | no | 0.75 | 0.6 | no dnr | 17 | 69 | 14.298828 | 70 | 28 | 38 | 450 | 3.599609 | 1 | 1.699951 | 136 | 7.419922 | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
2,263 | 31.034 | 1 | male | 1 | 24 | 24 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 8 | under $11k | 0 | 71,576 | 25,119.9688 | null | 42 | white | 36.195313 | 48 | 0.740967 | 0.659912 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 21 | 50 | 13 | 122 | 8 | 33.39844 | 240 | 2.699707 | 0.399963 | 0.599976 | 138 | 7.419922 | null | null | null | null | null | <2 mo. follow-up | 2.305664 |
2,264 | 85.52997 | 1 | female | 0 | 17 | 31 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 76,341 | 44,854.9688 | null | 11.333328 | white | 22.699219 | 39 | 0.580933 | 0.387939 | 52 | 0 | 1 | no | null | 0.5 | no dnr | 17 | 121 | 17.398438 | 118 | 30 | 37.79688 | 276 | 3.599609 | 0.399963 | 0.5 | 135 | 7.269531 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
2,265 | 84.42395 | 1 | female | 0 | 7 | 837 | CHF | COPD/CHF/Cirrhosis | 2 | 14 | $11-$25k | 0 | 8,777 | 3,951.0606 | null | 13 | white | 15.699219 | 32 | 0.850952 | 0.754883 | 1 | 1 | 0 | no | 0.4 | 0.1 | no dnr | 7 | 68 | 8.599609 | 58 | 28 | 37.79688 | 402 | null | 0.699951 | 1 | 136 | 7.459961 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
2,266 | 43.62997 | 0 | female | 0 | 34 | 1,442 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 20 | >$50k | 0 | 44,202 | 24,045.0938 | null | 17.5 | white | 26.898438 | 37 | 0.835938 | 0.780884 | 1 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 34 | 53 | 11.199219 | 110 | 26 | 38.89844 | 557.125 | 2.099609 | 0.699951 | 0.799927 | 132 | 7.399414 | null | null | null | 7 | null | SIP>=30 | 5.199497 |
2,267 | 59.48798 | 0 | male | 0 | 33 | 1,444 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | under $11k | 0 | 54,994 | 34,875.8125 | null | 30.75 | black | 33.195313 | 58 | 0.664917 | 0.567993 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 33 | 60 | 30 | 135 | 44 | 38.69531 | 97.5 | 2.299805 | 0.799927 | 0.799927 | 132 | 7.40918 | null | null | null | null | null | SIP>=30 | 2.629883 |
2,268 | 36.22699 | 1 | male | 0 | 16 | 314 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 0 | 37,450 | 17,838.1719 | null | 16.333328 | white | 21.898438 | 14 | 0.901978 | 0.866943 | 1 | 0 | 0 | no | null | null | no dnr | 16 | 111 | 11.398438 | 120 | 22 | 38.69531 | 201 | 4 | 1 | 1.199951 | 136 | 7.539062 | null | null | null | null | null | no(M2 and SIP pres) | 2.453125 |
2,269 | 86.68896 | 1 | male | 0 | 31 | 1,298 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | null | 0 | 63,310 | 33,241.6875 | null | 15 | white | 21 | 50 | 0.711914 | 0.623901 | 10 | 1 | 0 | no | 0.2 | 0.1 | no dnr | 31 | 113 | 25.097656 | 70 | 40 | 38.5 | null | 2.5 | 1.099854 | 2 | 142 | null | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
2,270 | 84.15594 | 1 | male | 0 | 15 | 1,408 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 17 | null | 0 | 21,427 | 10,362.7969 | null | 15.333328 | white | 30 | 32 | 0.602905 | 0.495972 | 1 | 0 | 0 | no | null | null | no dnr | 15 | 67 | 6.5 | 60 | 24 | 38.69531 | 108.32812 | 4.599609 | 0.699951 | 1.299805 | 123 | 7.40918 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,271 | 78.54895 | 1 | male | 0 | 3 | 479 | Lung Cancer | Cancer | 2 | 11 | under $11k | 0 | 2,752 | 1,697.4912 | null | 8 | white | 16.597656 | 13 | 0.682983 | 0.388977 | 1 | 0 | 0 | metastatic | null | null | no dnr | 3 | 83 | 3.699707 | 80 | 20 | 36.69531 | null | null | null | 0.799927 | 131 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
2,272 | 86.80597 | 1 | male | 1 | 14 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 20 | >$50k | 0 | 46,091 | 40,561.875 | null | 29.333328 | white | 34.695313 | 60 | 0.458984 | 0.339966 | 1 | 0 | 0 | no | 0.2 | 0.1 | dnr after sadm | 2 | 43 | 9.5 | 66 | 12 | 38.09375 | 150 | 2.799805 | 0.599976 | 5.699219 | 136 | 7.30957 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
2,273 | 73.82599 | 1 | male | 0 | 10 | 26 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 0 | 10,333 | 6,035.9219 | null | 10 | white | 21.796875 | 33 | 0.810913 | 0.694946 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 10 | 70 | 10.599609 | 108 | 25 | 36.69531 | 323.75 | null | null | 1.599854 | 138 | 7.469727 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
2,274 | 62.92999 | 1 | male | 1 | 19 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 0 | 48,246 | 18,903.375 | null | 40.333313 | white | 26.097656 | 34 | 0.782959 | 0.711914 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 19 | 111 | 14.699219 | 115 | 28 | 37.89844 | 150 | 2.399902 | null | 1 | 149 | 7.369141 | null | null | null | null | null | <2 mo. follow-up | 2.666992 |
2,275 | 55.06897 | 1 | male | 0 | 4 | 614 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 0 | 8,824 | 2,768.0117 | null | 25 | other | 22.097656 | 25 | 0.824951 | 0.765991 | 1 | 0 | 0 | yes | 0.9 | 0.9 | no dnr | 4 | 63 | 12.199219 | 103 | 12 | 38.29688 | 187.75 | 3.099609 | null | 1.399902 | 142 | 7.439453 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
2,276 | 72.91199 | 1 | male | 0 | 4 | 18 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | null | 0 | 3,901 | 2,315.2656 | null | 6 | white | 21.898438 | 35 | 0.812988 | 0.696899 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 73 | 10 | 80 | 20 | 36.69531 | 102.5 | null | 0.599976 | 1.099854 | 135 | 7.439453 | null | null | null | null | null | <2 mo. follow-up | 2.369629 |
2,277 | 84.72595 | 1 | female | 0 | 19 | 79 | COPD | COPD/CHF/Cirrhosis | 1 | null | under $11k | 0 | 29,354 | 22,675 | null | 20.666656 | white | 27.097656 | 46 | 0.599976 | 0.409973 | 1 | 0 | 0 | no | 0.15 | 0.05 | dnr after sadm | 2 | 50 | 10 | 48 | 8 | 36.29688 | 248.5625 | null | null | 1.5 | 146 | 7.489258 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
2,278 | 41.43698 | 1 | female | 0 | 7 | 61 | MOSF w/Malig | ARF/MOSF | 1 | 18 | >$50k | 0 | 23,016 | 13,218.8906 | null | 27 | white | 24 | 32 | 0.696899 | 0.605957 | 3 | 0 | 0 | yes | 0.8 | 0.5 | no dnr | 7 | 76 | 0.299988 | 80 | 24 | 36.09375 | null | 2.5 | 1.099854 | 1.199951 | 139 | null | null | null | null | 0 | null | null | 0.4948 |
2,279 | 55.97299 | 0 | male | 0 | 15 | 1,433 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 9 | 20,538 | 10,286.8125 | null | 12 | other | 29 | 30 | 0.735962 | 0.653931 | 1 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 15 | 63 | 9.398438 | 115 | 40 | 36.09375 | 128.3125 | 3 | 1 | 0.899902 | 135 | 7.359375 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
2,280 | 85.01294 | 1 | female | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 100 | 12,527 | 4,269.3672 | null | 29 | white | 33.59375 | 62 | 0.054993 | 0.017998 | 1 | 0 | 0 | no | null | null | dnr after sadm | 4 | 49 | 0.799927 | 75 | 8 | 36 | 366.625 | 2 | 0.299988 | 1.299805 | 129 | 7.299805 | null | null | null | null | null | <2 mo. follow-up | 3.848633 |
2,281 | 76.09296 | 1 | male | 0 | 7 | 499 | MOSF w/Malig | ARF/MOSF | 2 | 12 | null | 0 | 9,274 | 5,036.4609 | null | 14 | white | 15.599609 | 29 | 0.824951 | 0.765991 | 1 | 0 | 0 | yes | 1 | 1 | no dnr | 7 | 97 | 7.5 | 70 | 20 | 36.09375 | 223.78125 | null | 0.799927 | 1.299805 | 136 | 7.399414 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,282 | 76.70898 | 1 | female | 0 | 4 | 375 | Colon Cancer | Cancer | 3 | null | null | 0 | 4,285 | 2,603.9785 | null | 12 | white | 8.199219 | 12 | 0.893921 | 0.756958 | 1 | 1 | 0 | metastatic | 0.75 | 0.2 | no dnr | 4 | 83 | 7.599609 | 80 | 20 | 38.89844 | null | 4 | 0.399963 | 0.699951 | 136 | null | null | null | null | 1 | null | null | 1.1669 |
2,283 | 79.96399 | 1 | male | 1 | 24 | 24 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | under $11k | 0 | 31,577 | 17,898.6719 | null | 15.333328 | white | 21.097656 | 34 | 0.69397 | 0.601929 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | dnr after sadm | 1 | 83 | 9.099609 | 80 | 20 | 35.59375 | 180 | 2.199707 | null | 0.599976 | 135 | 7.469727 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
2,284 | 78.60394 | 0 | female | 0 | 21 | 1,426 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 7 | under $11k | 0 | 54,833 | 28,931.3906 | null | 24.666656 | white | 21.296875 | 31 | 0.755981 | 0.678955 | 6 | 1 | 0 | no | 1 | 1 | no dnr | 21 | 120 | 10.798828 | 68 | 8 | 38.09375 | 232.5 | null | 0.699951 | 3.299805 | 145 | 7.339844 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
2,285 | 67.73395 | 1 | female | 0 | 7 | 73 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 12 | null | 9 | 9,907 | 4,264.9141 | null | 20 | white | 22.5 | 31 | 0.661987 | 0.487976 | 1 | 0 | 0 | no | 0.3 | 0.2 | no dnr | 7 | 113 | 6.699219 | 54 | 12 | 35.89844 | 642.75 | 2.699707 | 3.5 | 0.799927 | 142 | 7.469727 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
2,286 | 84.68396 | 1 | female | 0 | 21 | 741 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 8 | under $11k | 0 | 28,225 | 11,972.6172 | null | 11 | white | 35.398438 | 50 | 0.426941 | 0.306946 | 2 | 1 | 0 | no | 0.6 | 0.5 | dnr after sadm | 2 | 77 | 10.898438 | 132 | 26 | 36.09375 | 120 | null | 0.799927 | 2.5 | 141 | 7.30957 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,287 | 63.59799 | 0 | male | 0 | 7 | 1,424 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 15,332 | 8,985.8438 | null | 11 | white | 15.298828 | 25 | 0.905884 | 0.841919 | 1 | 1 | 0 | no | 0.9 | 0.6 | no dnr | 7 | 63 | 10.199219 | 70 | 28 | 36.59375 | null | 3.599609 | 0.799927 | 1 | 139 | 7.479492 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,288 | 86.75397 | 1 | female | 1 | 35 | 35 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 0 | 87,011 | 26,562.7031 | null | 32.5 | white | 35.09375 | 66 | 0.348999 | 0.159973 | 1 | 0 | 0 | no | 0.85 | 0.7 | dnr after sadm | 10 | 51 | 17 | 65 | 38 | 36.19531 | 146.40625 | null | 0.199982 | 2.799805 | 142 | 7.30957 | null | null | null | 2 | 2 | <2 mo. follow-up | 2 |
2,289 | 77.65094 | 1 | male | 0 | 21 | 26 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 44 | 29,557 | 14,287.6953 | null | 23.333328 | white | 26.796875 | 42 | 0.523926 | 0.407959 | 1 | 0 | 1 | no | 0.75 | 0.6 | no dnr | 21 | 71 | 9.398438 | 63 | 8 | 37.79688 | 108.23438 | 2.599609 | 0.799927 | 2.799805 | 139 | 7.439453 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
2,290 | 78.87195 | 0 | male | 0 | 30 | 1,421 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | $11-$25k | 0 | 59,878 | 45,923.1562 | null | 24.75 | white | 21.199219 | 23 | 0.767944 | 0.69397 | 4 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 30 | 117 | 7.5 | 50 | 8 | 38.39844 | 128 | null | null | 1.099854 | 144 | 7.419922 | null | null | null | null | 0 | null | 0 |
2,291 | 83.20294 | 0 | female | 0 | 7 | 1,421 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | $11-$25k | 0 | 8,495 | 4,689.9648 | null | 12 | white | 15.798828 | 30 | 0.853882 | 0.758911 | 1 | 1 | 0 | no | 0.95 | 0.8 | no dnr | 7 | 77 | 8.298828 | 70 | 20 | 36.09375 | 304.75 | 3.399902 | null | 1 | 141 | 7.469727 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
2,292 | 85.30597 | 1 | female | 0 | 12 | 294 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 23,144 | 17,423.9844 | null | 26.5 | white | 25.296875 | 47 | 0.639893 | 0.537964 | 1 | 0 | 0 | yes | 0.98 | 0.941 | no dnr | 12 | 60 | 41 | 80 | 31 | 36.79688 | 114 | null | null | 1 | 134 | 7.5 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
2,293 | 77.23999 | 0 | male | 0 | 5 | 1,420 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | $11-$25k | 0 | 4,915 | 2,881.0078 | null | 9 | white | 16.796875 | 26 | 0.825928 | 0.715942 | 1 | 0 | 0 | yes | 0.8 | 0.6 | no dnr | 5 | 73 | 6.099609 | 80 | 20 | 36.09375 | null | null | null | 1.599854 | 140 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
2,294 | 86.13599 | 1 | female | 0 | 9 | 1,027 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 9,257 | 5,256.9336 | null | 12.5 | white | 16 | 25 | 0.841919 | 0.740967 | 1 | 0 | 0 | no | 0.9 | 0.85 | no dnr | 9 | 103 | null | 80 | 20 | 36.09375 | 544 | 3.699707 | null | 1.699951 | 139 | 7.489258 | null | null | null | null | null | null | 3.155762 |
2,295 | 85.51398 | 1 | female | 0 | 8 | 625 | CHF | COPD/CHF/Cirrhosis | 3 | 9 | under $11k | 0 | 6,524 | 4,043.3086 | null | 8.5 | white | 15.199219 | 20 | 0.853882 | 0.758911 | 1 | 0 | 0 | no | 0.95 | 0.5 | dnr after sadm | 3 | 83 | 4.799805 | 70 | 20 | 36.69531 | 408.3125 | 3.899902 | null | 1.699951 | 138 | 7.389648 | null | null | null | 2 | 2 | no(M2 and SIP pres) | 2 |
2,296 | 35.96997 | 0 | female | 0 | 5 | 1,418 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 7,688 | 3,634.7578 | null | 15 | white | 20.296875 | 11 | 0.91394 | 0.882935 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 73 | 15.099609 | 80 | 20 | 37.79688 | 125 | 2.699707 | 0.299988 | 0.899902 | 143 | 7.429688 | null | null | null | null | null | null | 2.608398 |
2,297 | 79.86896 | 0 | female | 0 | 16 | 1,418 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 0 | 18,921 | 9,482.1172 | null | 13.333328 | white | 27.898438 | 45 | 0.675903 | 0.580933 | 1 | 1 | 0 | no | 0.75 | 0.75 | dnr after sadm | 3 | 49 | 5.799805 | 74 | 28 | 36.59375 | 230.59375 | 2.799805 | null | 1.099854 | 128 | 7.479492 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
2,298 | 65.91595 | 0 | male | 0 | 12 | 1,415 | Coma | Coma | 4 | 12 | $11-$25k | 26 | 29,515 | 14,788.8281 | null | 24.5 | white | 17.398438 | 21 | 0.67688 | 0.620972 | 4 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 12 | 123 | 7.899414 | 102 | 10 | 36.79688 | null | 3.299805 | 0.299988 | 1 | 137 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
2,299 | 83.37 | 1 | male | 0 | 35 | 150 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 17 | null | 0 | 71,015 | 43,051.8438 | null | 23.5 | white | 23.898438 | 53 | 0.707886 | 0.619995 | 3 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 35 | 55 | 18.796875 | 63 | 28 | 36 | 428 | 2.099609 | 0.5 | 1.399902 | 135 | 7.5 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
2,300 | 63.91498 | 1 | male | 0 | 10 | 141 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 10,359 | 6,967.9688 | null | 12.5 | white | 21.796875 | 38 | 0.737915 | 0.587891 | 1 | 1 | 0 | no | 0.9 | 0.7 | no dnr | 10 | 73 | 7.899414 | 70 | 20 | 36.69531 | null | 3.399902 | 0.799927 | 2.199707 | 129 | null | null | null | null | 6 | null | SIP>=30 | 4.527397 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.